Infectious diseases Archives - Page 3 of 29

Podcasts

COVID update – Recent statistics and recent ATAGI updates

Basic statistics, epidemiology, and important events, and new variants and subvariants

Clinical Articles

Malaria cases on the rise

As international lockdowns start to feel like a memory of a bad dream

Clinical Articles

Live 8cm worm found residing in woman’s brain

An 8 cm roundworm that would usually be more at home in a carpet python was pulled live from a woman’s brain, in a case that had baffled a team of specialists for more than a year.

Podcasts

COVID update – Eris, pirola and other developments

New variants (Eris, Pirola) and ATAGI guidelines

Clinical Articles

The WHO has declared Eris a ‘variant of interest’. How is it different from other Omicron variants?

The World Health Organization (WHO) classified it as a “variant under monitoring” on July 19 after a surge in COVID

Podcasts

COVID update from ATAGI

Booster confusion and are protein-based vaccines more likely to attract people?

Clinical Articles

Long COVID: brain function still affected for some up to two years after infection – new research

Difficulties with cognitive functions or skills, such as the ability to recall memories, concentrate on tasks, or find the right words in conversation, are commonly reported following a COVID infection.

Videos

New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3

In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Podcasts

COVID-19 – The latest information

Molnupiravir is still effective and protecting your most vulnerable patients

Clinical Articles

Common diabetes drug metformin could protect against long COVID

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Videos

Protein based COVID-19 vaccine

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access (8 mins).

Podcasts

COVID update – Boosters, side effects, new waves

Vaccine-related injury, long COVID, more on boosters.

Infectious diseases

COVID update – Recent statistics and recent ATAGI updates

Basic statistics, epidemiology, and important events, and new variants and subvariants

Malaria cases on the rise

As international lockdowns start to feel like a memory of a bad dream

Live 8cm worm found residing in woman’s brain

An 8 cm roundworm that would usually be more at home in a carpet python was pulled live from a woman’s brain, in a case that had baffled a team of specialists for more than a year.

COVID update – Eris, pirola and other developments

New variants (Eris, Pirola) and ATAGI guidelines

The WHO has declared Eris a ‘variant of interest’. How is it different from other Omicron variants?

The World Health Organization (WHO) classified it as a “variant under monitoring” on July 19 after a surge in COVID

COVID update from ATAGI

Booster confusion and are protein-based vaccines more likely to attract people?

Long COVID: brain function still affected for some up to two years after infection – new research

Difficulties with cognitive functions or skills, such as the ability to recall memories, concentrate on tasks, or find the right words in conversation, are commonly reported following a COVID infection.

New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3

COVID-19 – The latest information

Molnupiravir is still effective and protecting your most vulnerable patients

Common diabetes drug metformin could protect against long COVID

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Protein based COVID-19 vaccine

COVID update – Boosters, side effects, new waves

Vaccine-related injury, long COVID, more on boosters.

Get the app

Site

Company

Connect

Legal

Healthed

Infectious diseases

Basic statistics, epidemiology, and important events, and new variants and subvariants

As international lockdowns start to feel like a memory of a bad dream

An 8 cm roundworm that would usually be more at home in a carpet python was pulled live from a woman’s brain, in a case that had baffled a team of specialists for more than a year.

New variants (Eris, Pirola) and ATAGI guidelines

The World Health Organization (WHO) classified it as a “variant under monitoring” on July 19 after a surge in COVID

Booster confusion and are protein-based vaccines more likely to attract people?

Difficulties with cognitive functions or skills, such as the ability to recall memories, concentrate on tasks, or find the right words in conversation, are commonly reported following a COVID infection.

Molnupiravir is still effective and protecting your most vulnerable patients

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Vaccine-related injury, long COVID, more on boosters.

Get the app

Site

Company

Connect

Legal

Extra Details

Healthed